Financial Management Professionals’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92K | Sell |
35
-6
| -15% | -$330 | ﹤0.01% | 756 |
|
|
2025
Q1 | $2.9K | Buy |
41
+6
| +17% | +$424 | ﹤0.01% | 699 |
|
|
2024
Q4 | $2.3K | Hold |
35
| – | – | ﹤0.01% | 714 |
|
|
2024
Q3 | $2K | Sell |
35
-10
| -22% | -$571 | ﹤0.01% | 730 |
|
|
2024
Q2 | $4K | Buy |
45
+10
| +29% | +$889 | ﹤0.01% | 602 |
|
|
2024
Q1 | $3K | Hold |
35
| – | – | ﹤0.01% | 689 |
|
|
2023
Q4 | $3K | Hold |
35
| – | – | ﹤0.01% | 697 |
|
|
2023
Q3 | $3K | Hold |
35
| – | – | ﹤0.01% | 651 |
|
|
2023
Q2 | $3K | Hold |
35
| – | – | ﹤0.01% | 695 |
|
|
2023
Q1 | $3K | Hold |
35
| – | – | ﹤0.01% | 744 |
|
|
2022
Q4 | $4K | Hold |
35
| – | – | ﹤0.01% | 644 |
|
|
2022
Q3 | $3K | Hold |
35
| – | – | ﹤0.01% | 662 |
|
|
2022
Q2 | $3K | Hold |
35
| – | – | ﹤0.01% | 681 |
|
|
2022
Q1 | $3K | Hold |
35
| – | – | ﹤0.01% | 698 |
|
|
2021
Q4 | $3K | Hold |
35
| – | – | ﹤0.01% | 643 |
|
|
2021
Q3 | $3K | Hold |
35
| – | – | ﹤0.01% | 642 |
|
|
2021
Q2 | $3K | Buy |
+35
| New | +$3K | ﹤0.01% | 587 |
|
|
2019
Q2 | – | Sell |
-29
| Closed | -$3K | – | 317 |
|
|
2019
Q1 | $3K | Hold |
29
| – | – | ﹤0.01% | 213 |
|
|
2018
Q4 | $2K | Hold |
29
| – | – | ﹤0.01% | 224 |
|
|
2018
Q3 | $3K | Buy |
+29
| New | +$3K | ﹤0.01% | 227 |
|